LOAMU
AEON.WS

Lombard Odier Asset Management (USA)’s AEON Biopharma Inc AEON.WS Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-41,666
Closed -$12K – 447
2022
Q1 		$12K Hold
41,666
– – ﹤0.01% 305
2021
Q4 		$21K Buy
+41,666
New +$23K ﹤0.01% 334

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AEON.WS Position: Q3 2023 in Review

Lombard Odier Asset Management (USA) sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 41,666 shares — an estimated $3.75K sold.

Lombard Odier Asset Management (USA) first reported a position in AEON.WS in Q3 2022 and held it in 2 quarters. The position peaked at $3.75K in Q2 2023. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

  • Lombard Odier Asset Management (USA) reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 41,666 AEON Biopharma Inc shares in Q3 2023, an estimated $3.75K.
  • Lombard Odier Asset Management (USA) first reported a position in AEON Biopharma Inc in Q3 2022 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s AEON Biopharma Inc position peaked at $3.75K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2023, filed 14 Nov 2023.